| scholarly article | Q13442814 |
| P2093 | author name string | Liangfang Zhang | |
| Weiwei Gao | |||
| Soracha Thamphiwatana | |||
| Pavimol Angsantikul | |||
| P2860 | cites work | Bacterial outer membrane vesicles and vaccine applications | Q24568229 |
| Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform | Q24596232 | ||
| Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy | Q27488746 | ||
| High yield production process for Shigella outer membrane particles | Q28728768 | ||
| Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia | Q28728777 | ||
| Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells | Q29615461 | ||
| Immunological properties of engineered nanomaterials | Q29615634 | ||
| Bacterial membrane proteomics. | Q30371935 | ||
| Polymer particles that switch shape in response to a stimulus | Q30495236 | ||
| Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions | Q30543404 | ||
| Biopolymer implants enhance the efficacy of adoptive T-cell therapy. | Q30614247 | ||
| Peptide imprinted polymer nanoparticles: a plastic antibody | Q33378659 | ||
| A self-assembling peptide acting as an immune adjuvant | Q33640064 | ||
| pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides | Q33703757 | ||
| Delivery of foreign antigens by engineered outer membrane vesicle vaccines | Q33733590 | ||
| Targeting bacterial toxins | Q37996325 | ||
| Engineering approaches to immunotherapy. | Q38036894 | ||
| Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships | Q38153040 | ||
| Engineering synthetic vaccines using cues from natural immunity | Q38154804 | ||
| Nanoparticle vaccines | Q38167942 | ||
| Molecular mechanisms of antibiotic resistance. | Q38272908 | ||
| Gram-negative and Gram-positive bacterial extracellular vesicles | Q38363971 | ||
| Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery | Q39005991 | ||
| Development of improved cholera vaccine based on subunit toxoid | Q39459483 | ||
| A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection. | Q39951061 | ||
| Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. | Q40077642 | ||
| Maximizing DNA loading on a range of gold nanoparticle sizes | Q42002145 | ||
| Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. | Q43012213 | ||
| Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice | Q43623067 | ||
| Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation | Q44300085 | ||
| Identification of formaldehyde-induced modifications in proteins: reactions with model peptides | Q44669066 | ||
| Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells | Q46394896 | ||
| Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype | Q47097020 | ||
| The perpetual challenge of infectious diseases | Q48489280 | ||
| Tackling antibiotic resistance: the environmental framework | Q48544038 | ||
| Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. | Q53530186 | ||
| Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin. | Q53904617 | ||
| Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. | Q54297240 | ||
| Staphylococcal Infection: Antitoxic Immunity | Q78856849 | ||
| "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells | Q80212165 | ||
| Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine | Q83393108 | ||
| Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses | Q83875789 | ||
| Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide™ ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens | Q84411461 | ||
| Surface functionalization of gold nanoparticles with red blood cell membranes | Q34067202 | ||
| Staphylococcus aureus produces membrane-derived vesicles that induce host cell death | Q34082984 | ||
| Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model | Q34154110 | ||
| Nanotoxoid Vaccines | Q34268613 | ||
| Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines | Q34301234 | ||
| Protein secretion and the pathogenesis of bacterial infections | Q34311542 | ||
| Role of pore-forming toxins in bacterial infectious diseases | Q34346202 | ||
| Bacterial outer membrane vesicles and the host-pathogen interaction | Q34468123 | ||
| Staphylococcus aureus α-toxin-dependent induction of host cell death by membrane-derived vesicles | Q34575574 | ||
| Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses | Q34802680 | ||
| Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. | Q35053924 | ||
| Vaccines, Vaccination, and Vaccinology | Q35115796 | ||
| Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy | Q35304894 | ||
| Modulating antibacterial immunity via bacterial membrane-coated nanoparticles | Q35447934 | ||
| Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection | Q35706529 | ||
| Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction | Q35709003 | ||
| Reorienting our view of particle-based adjuvants for subunit vaccines | Q35709212 | ||
| Synthesis of Nanogels via Cell Membrane-Templated Polymerization | Q36037531 | ||
| Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery | Q36331113 | ||
| Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae. | Q36334594 | ||
| Vaccine delivery using nanoparticles. | Q36712817 | ||
| A biomimetic nanosponge that absorbs pore-forming toxins | Q36828355 | ||
| 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach | Q36886925 | ||
| Engineering nano- and microparticles to tune immunity | Q37205125 | ||
| Nanoparticle-detained toxins for safe and effective vaccination | Q37426321 | ||
| Existing antibacterial vaccines | Q37428005 | ||
| Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination | Q37603557 | ||
| Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles | Q37638568 | ||
| Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery | Q37701353 | ||
| Targeted immunomodulation using antigen-conjugated nanoparticles | Q37705215 | ||
| Bacterial outer membrane vesicles in disease and preventive medicine | Q37820396 | ||
| Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines | Q37860707 | ||
| Review of diphtheria, tetanus and pertussis vaccines in clinical development | Q37878479 | ||
| Bio-inspired, bioengineered and biomimetic drug delivery carriers | Q37896455 | ||
| Modulating immunity as a therapy for bacterial infections | Q37994068 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 814-28 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Vaccines | Q27725508 |
| P1476 | title | Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform | |
| P478 | volume | 3 |
| Q26744748 | Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases |
| Q66679228 | Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases |
| Q89622549 | Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics |
| Q49822345 | Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance |
| Q97074379 | Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications |
| Q41430285 | Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy |
| Q38677432 | Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook. |
| Q47302175 | The Diverse Range of Possible Cell Membrane Interactions with Substrates: Drug Delivery, Interfaces and Mobility. |
Search more.